1. Home
  2. Labeler Index
  3. Sagent Pharmaceuticals
  4. 25021-254
  5. NDC Package Code: 25021-254-08 Docetaxel

NDC Package 25021-254-08 Docetaxel

Docetaxel Anhydrous Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25021-254-08
Package Description:
1 VIAL in 1 CARTON / 8 mL in 1 VIAL
Product Code:
25021-254
Proprietary Name:
Docetaxel
Non-Proprietary Name:
Docetaxel Anhydrous
Substance Name:
Docetaxel Anhydrous
Usage Information:
This medication is used to treat cancer (such as breast, lung, prostate, stomach, and head/neck cancer). Docetaxel is a member of a family of drugs called taxanes. This drug works by slowing cell growth.
11-Digit NDC Billing Format:
25021025408
NDC to RxNorm Crosswalk:
  • RxCUI: 1093280 - DOCEtaxel 10 MG/ML Injectable Solution
  • RxCUI: 1093280 - docetaxel 10 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sagent Pharmaceuticals
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • DOCETAXEL ANHYDROUS 10 mg/mL
    • Pharmacologic Class(es):
  • Microtubule Inhibition - [PE] (Physiologic Effect)
  • Microtubule Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA213510
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-01-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    25021-254-161 VIAL in 1 CARTON / 16 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25021-254-08?

    The NDC Packaged Code 25021-254-08 is assigned to a package of 1 vial in 1 carton / 8 ml in 1 vial of Docetaxel, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 25021-254 included in the NDC Directory?

    Yes, Docetaxel with product code 25021-254 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on August 01, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 25021-254-08?

    The 11-digit format is 25021025408. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225021-254-085-4-225021-0254-08